摘要:
As new compound are now provided ten compounds, namely 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-kanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybuty- ryl}-2',3'-dideoxykanamycin A; 1-N-{(2R,3R)-4-amino-fluoro-2-hydorxybutyryl}-2',3'-dideoxy-2'-fluorokanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin A; 1-N-((2R,3R)-4-amino-fluoro-2-hydrox- ybutyryl}-kanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hy- droxybutyryl}-3'-deoxykanamycin B; 1-N-((2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3',4'-dideoxykanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydrox- ybutyryl}-5,3'-dideoxy-5-fluorokanamycin B; and 1-N{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3',4'-tride- oxy-5-fluorokanamycin B, which are all useful as antibacterial agent in the therapeutic treatment of bacterial infections.
摘要:
As new compounds are now provided 5-deoxy-5-fluorokanamycin B, 5,3'-dideoxy-5-fluorokanamycin B, 5,4'- dideoxy-5-fluorokanamycin B and 5,3',4'-trideoxy-5-fluorokanamycin B as well as 1-N-(3-amino-2-hydrox- ypropionyl)-or 1-N-(4-amino-2-hydroxybutyryl)-derivatives thereof which are all useful as antibacterial agents and exhibit improved antibacterial activities. These new compounds may be produced by synthetic processes starting from an appropriately N,O-protected 5-epi-kanamycin B, 3'-deoxy-5-epi-kanamycin B, 4'-deoxy-5-epi-kanamycin B or 3',4'-dideoxy-5-epi-kanamycin B derivative which is now prepared by a combination of reaction steps.
摘要:
A tylosin derivative represented by the general formula wherein R. represents a hydrogen atom or a hydroxyl group and R. represents (wherein R 9 and R 10 may be the same or different and selected from a hydrogen atom and C, to C. alkyl groups or which may together form an alkylene group having 3-7 carbon atoms) or -S-R 11 (wherein R " represents a furanyl group or a pyridyl group).
摘要:
As new compound are now provided ten compounds, namely 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-kanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybuty- ryl}-2',3'-dideoxykanamycin A; 1-N-{(2R,3R)-4-amino-fluoro-2-hydorxybutyryl}-2',3'-dideoxy-2'-fluorokanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin A; 1-N-((2R,3R)-4-amino-fluoro-2-hydrox- ybutyryl}-kanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hy- droxybutyryl}-3'-deoxykanamycin B; 1-N-((2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3',4'-dideoxykanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydrox- ybutyryl}-5,3'-dideoxy-5-fluorokanamycin B; and 1-N{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3',4'-tride- oxy-5-fluorokanamycin B, which are all useful as antibacterial agent in the therapeutic treatment of bacterial infections.
摘要:
As new anthracycline derivatives are now produced 7-O-(2,6-dideoxy-2-fluoro-a-L-mannopyranosyl)-daunomycinone and -adriamycinone, their 4-demethoxy derivatives and 14-0-ester derivatives of the adriamycinone compounds of them, as well as 4-demethoxy-7-0-(2,6-dideoxy-2-fluoro-α-L-talopyranosyl)-daunomycinone and -adriamycinone and 14-0-ester derivatives of the adriamycinone compound thereof which )exhibit excellent antitumor activities and are useful as antitumor agents. These new anthracycline derivatives may be produced by various processes.
摘要:
2.6-Dideoxy-2-fluoro-L-talopyranose and I-substituted denvatives thereof. including methyl 2.6-dideoxy-2-fluoro-L-talopyranoside and 3.4-di-O-protected-2,6-dfdeoxy-2-fluoro-L-ta- lopyranosyl halides. are now provided and these new compounds are useful as intermediates for use in the synthesis of new compounds having antitumor activity. especially 7-O-(2.6-dideoxy-2-fluoro-α-L-talopyranosyl)daunomycinone or -adriamycinone. 2.6-Dideoxy-2-fluoro-L-talopyranose shows antibacterial activity. 2.6-Dideoxy-2-fluoro-L-talopyranose and the I-substituted derivatives thereof may be produced by a multi-stage process starting from L-fucose.
摘要:
As new anthracycline derivatives are now provided 7-0-(2,6-dideoxy-2-fluoro-a-L-talopyranosyl)-daunomycinone and 7-0-(2,6-dideoxy-2-fluoro-a-L-talopyranosyl)adriamycinone which are useful as antitumor agent and also as antibacterial agent. Briefly, these new compounds may be produced by condensing a 2,6- dideoxy-2-fluoro-a-L-talopyranosyl halide with the 7-hydroxyl group of daunomycinone or adriamycinone.
摘要:
To provide novel fluorine-containing anthracycline derivatives having high antitumor activities and a solubility in water, there have now been synthesized a 7-O-(2,6-dideoxy-2-fluoro-3-O- or -4-O- or -3,4-di-O-aminoalkanoyl-α-L-talopyranosyl)daunomycinone or -adriamycinone of general formula (I) shown below, as well as a 7-O-(3-O- or -4-O-or -3,4-di-O-aminoalkanoyl-2,6-dideoxy-2,6,6,6-tetrafluoro-α-L-talopyranosyl- or -2,6-dideoxy-6,6,6-trifluoro-α-L-lyxo-hexopyranosyl)adriamycinone of general formula (II) shown below:-
wherein either one or both of A 1 and A 2 is or are an α-amino acid residue or an ω-amino acid residue and T denotes a fluorine or hydrogen atom. The novel fluorine-containing anthracycline derivatives of general formulae (I) and (II) are highly active against tumors and soluble in water, and they are useful as antitumor agents administrable in the form of injectable solution.